Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura De Marinis

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Reviews in Endocrine & Metabolic Disorders|January 19, 2023
The immune microenviroment in somatotropinomas: from biology to personalized and target therapySabrina Chiloiro, Laura De Marinis
Endocrine, Metabolic & Immune Disorders Drug Targets|August 24, 2021
From Pituitary Adenoma to Pituitary Neuroendocrine Tumors: How Molecular Pathways may Impact the Therapeutic Management?Sabrina Chiloiro, Laura De Marinis
European Journal of Endocrinology|November 17, 2017
Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitisSabrina Chiloiro, Laura De Marinis
Handbook of Clinical Neurology|July 9, 2021
Empty sella syndrome: Multiple endocrine disordersSabrina Chiloiro, Antonella Giampietro, Antonio Bianchi, et al.
The Journal of Clinical Endocrinology and Metabolism|June 24, 2005
Primary empty sellaLaura De Marinis, Stefania Bonadonna, Antonio Bianchi, et al.
Pituitary|October 15, 2024
Hypophysitis in COVID-19: a systematic reviewSara Menotti, Luigi di Filippo, Umberto Terenzi, et al.
Clinical Endocrinology|February 6, 2008
Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinismDaniela Romualdi, Laura De Marinis, Giuseppe Campagna, et al.
Endocrine|February 22, 2023
De-escalation treatment with pasireotide for acromegaly: a long-term experienceAntonella Giampietro, Sara Menotti, Sabrina Chiloiro, et al.
Fertility and Sterility|July 9, 2004
Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndromePaola Villa, Laura De Marinis, Antonio Mancini, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|August 5, 2022
Second line treatment of acromegaly: Pasireotide or Pegvisomant?Sabrina Chiloiro, Antonio Bianchi, Antonella Giampietro, et al.
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Reviews in Endocrine & Metabolic Disorders|January 19, 2023
The immune microenviroment in somatotropinomas: from biology to personalized and target therapySabrina Chiloiro, Laura De Marinis
Endocrine, Metabolic & Immune Disorders Drug Targets|August 24, 2021
From Pituitary Adenoma to Pituitary Neuroendocrine Tumors: How Molecular Pathways may Impact the Therapeutic Management?Sabrina Chiloiro, Laura De Marinis
European Journal of Endocrinology|November 17, 2017
Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitisSabrina Chiloiro, Laura De Marinis
Handbook of Clinical Neurology|July 9, 2021
Empty sella syndrome: Multiple endocrine disordersSabrina Chiloiro, Antonella Giampietro, Antonio Bianchi, et al.
The Journal of Clinical Endocrinology and Metabolism|June 24, 2005
Primary empty sellaLaura De Marinis, Stefania Bonadonna, Antonio Bianchi, et al.
Pituitary|October 15, 2024
Hypophysitis in COVID-19: a systematic reviewSara Menotti, Luigi di Filippo, Umberto Terenzi, et al.
Clinical Endocrinology|February 6, 2008
Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinismDaniela Romualdi, Laura De Marinis, Giuseppe Campagna, et al.
Endocrine|February 22, 2023
De-escalation treatment with pasireotide for acromegaly: a long-term experienceAntonella Giampietro, Sara Menotti, Sabrina Chiloiro, et al.
Fertility and Sterility|July 9, 2004
Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndromePaola Villa, Laura De Marinis, Antonio Mancini, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|August 5, 2022
Second line treatment of acromegaly: Pasireotide or Pegvisomant?Sabrina Chiloiro, Antonio Bianchi, Antonella Giampietro, et al.
Pageof 15